Objectives: This study aims to investigate the correlation of ankylosing spondylitis (AS) with nephrolithiasis by performing a nationwide populationbased cohort study.
Ankylosing spondylitis (AS) is known as a chronic inflammatory rheumatic disorder which mainly affects the axial skeleton such as spinal and sacroiliac joints. In addition, AS sometimes affects the peripheral joints and nonarticular structures such as in associated diseases including acute uveitis, psoriasis, and inflammatory bowel disease. 1 The prevalence of AS in Taiwan is approximately 0.2% to 0.3% of its overall population, 2 which is similar to that of Europe as well as North America. 3 On the other hand, nephrolithiasis is known as a common urological disease with an average prevalence of 10% to 15% in world population. 4 Typical symptoms include renal colic and hematuria, while other symptoms such as radiating pain, and gastrointestinal and lower urinary tract symptoms are also common. 5 Most of the urinary stones (over 80%) are known to be calcium containing. Altered calcium metabolism and hyperuricemia have often been observed among severe AS patients or those with extensive disease duration. 6 Since AS patients tend to have a higher risk of inflammatory bowel disease, this further leads to patients' increased absorption of calcium and oxalate. 7 Overall, these circumstances raise our concern whether AS should considered as one of the many risk factors which might lead to nephrolithiasis.
Over the years, various population-based studies using the Taiwan National Health Insurance Research database (NHIRD) have been conducted to validate the correlations between nephrolithiasis and diseases such as osteoporosis, diabetes mellitus, and migraine. [8] [9] [10] Therefore, in this study, we aimed to investigate the correlation of AS with nephrolithiasis by performing a nationwide population-based cohort study.
PATIENTS AND METHODS
This study used reimbursement claims data from the Taiwan NHIRD. Taiwan's National Health Insurance program, which has been implemented by the government since March 1996, provides comprehensive health care to almost all Taiwanese citizens, with a coverage rate of more than 99% of Taiwan's entire population. The National Health Research Institute (NHRI) of Taiwan manages and publicly releases multiple National Health Insurance databases for research purposes. While the NHRI not only manages data from 19 medical centers, it also covers data collected from other regional hospitals, district hospitals as well as those clinics throughout Taiwan. These databases include information such as basic patient characteristics, date of visit, diagnoses codes for the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, detailed claims data for examinations, and disease management for all admitted patients and outpatients. The Longitudinal Health Insurance Database 2000 comprises a random sample of one million subjects from the NHIRD longitudinally linked data available from 1996 to 2011. Data sets of NHRI from 2000 to 2011 were selected to be used as our research database in this study. The comparison cohort, which referred to the non-AS population in this study, comprised subjects who were randomly selected from the same data used above. Each patient with newly diagnosed AS in the NHRI database was further pair-matched with three parameters which included the identical age (per 5 years), sex, and index year. The index date for non-AS was randomly assigned from January 1 st , 2000 to December 31 st , 2008, in accordance with the index date distribution of the AS cohort. Furthermore, the independent parameter "urbanization level" was used to categorize patients' registered residential areas within the NHRI database. As noted, there were five levels of urbanization in our study, which was calculated by incorporating variables including population density (people/km 2 ), population ratio of different education levels, population ratio of elderly, population ratio of people of agriculture workers, and the number of physicians per 100,000 people.
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In addition, for both the AS and non-AS cohorts, patients with nephrolithiasis (ICD-9-CM: 592 or 274.11) history before index date, those aged lower than 20, and those with incomplete information of age and sex were excluded.
New diagnosis of nephrolithiasis (ICD-9-CM: 592 or 274.11) in at least two records of outpatient or inpatient visits after the index date was defined as the primary outcome, while the time of follow-up started from the index date and ended on either the date with new diagnosis of nephrolithiasis or on December 31 st , 2011.
Demographic factors included age and sex. Age was divided into three groups: 20 to 39 years, 40 to 64 years, and those over 65 years. Comorbidity diseases were identified from the disease records in ICD-9-CM from outpatient and inpatient visits. Diabetes mellitus (ICD-9-CM: 250; A code: A181), hypertension (ICD-9-CM: 401-405; A code: A260, A269), hyperlipidemia (ICD-9-CM: 272; A code: A182), gout (ICD-9-CM: 274), coronary heart disease (ICD-9-CM: 410-414, 429.2; A code: A279), chronic kidney disease (ICD-9-CM: 585), and osteoporosis (ICD-9-CM: 733.0) were considered as comorbid medical disorders. If these diagnostic codes were used in two or more claims before the index date, they were recorded as comorbidities.
Statistical analysis
Comparisons between the groups were performed by using the Pearson's chi-square test to examine the difference between AS and non-AS cohorts. We then evaluated the cumulative risk of nephrolithiasis for both cohorts by using the Kaplan-Meier method, and the significance of the cumulative risk curves was assessed by using the log-rank test. The Cox's proportional hazards model was used to estimate the hazards ratio for the progression of outcome. In addition, the Cox proportional hazard model was also used to calculate the 95% confidence interval (CI) of nephrolithiasis compared between AS and non-AS cohorts. All analyses were carried out with the SAS statistical software (version 9.4 for Windows; SAS Institute, Inc., Cary, NC, USA). Statistical significance was determined as p<0.05. Table 1 shows baseline characteristics of study participants according to the status of AS. There were more male participants than females (57.41% vs 42.59%). The mean age of subjects with AS was 44.51±16.83 years. The mean follow-up periods for AS and non-AS patients were 6.78 years (median, 6.87 years) and 6.75 years (median, 6.92 years), respectively. The prevalence of AS was positively associated with urbanization level: the higher the urbanization level, the higher the prevalence of AS. The prevalence of diabetes mellitus, hypertension, hyperlipidemia, gout, coronary heart disease, and osteoporosis was significantly higher among patients with AS. The overall incidence rate of nephrolithiasis was higher in the AS cohort than the non-AS cohort. Additionally, males (10.10 per 1000 person-years) had a higher incidence rate of nephrolithiasis than females (6.36 per 1000 person-years) ( Table 3 ). The Kaplan-Meier analysis was conducted to compare the accumulative incidence of nephrolithiasis between the AS and the non-AS cohorts within follow-up periods of mean 6.78 and 6.75 years. Log rank test result showed a higher incidence rate of nephrolithiasis in the AS cohort than the non-AS cohort (p=0.0080) (Figure 1 ).
RESULTS

DISCUSSION
In our study, the AS cohort tended to have a higher risk of nephrolithiasis than the non-AS cohort. Though the phenomenon has not been clarified, few studies have investigated kidney stones formation among AS patients. For example, factors such as hypercalciuria, disturbed calcium and vitamin D metabolism, use of anti-inflammatory drugs, and immobilization have been suggested to cause nephrolithiasis in AS patients. 6, [12] [13] [14] [15] Furthermore, according to the ultrasonographic findings of their research, Korkmaz et al. 6 reported that 25% of patients with AS had renal stone formation. Also, the result of another population-based study (sample of 8,572 AS patients) in Sweden indicated that 4.0% of the AS patients and 1.8% of the general population comparators had received a diagnosis of nephrolithiasis at the end of the study period. 16 Additionally, Liu et al. 17 claimed that AS patients with DM or Crohn's disease were observed to have a higher risk of nephrolithiasis.
As discussed, AS is known to be associated with various comorbidities. In their study, Bremander et al. 18 suggested that AS was highly associated with comorbidities such as iridocyclitis, inflammatory bowel disease as well as cardiovascular diseases. While in another study, Szabo et al. 19 also stated that AS patients were more likely (at least 25% increased risk) to be associated with cardiovascular disease than the non-AS patients. In addition, Muñoz-Ortego et al. 20 argued that AS patients tended to have a higher risk of both clinical vertebral (0.86% versus 0.41%) and nonvertebral fractures (3.4% versus 2.7%) than the non-AS patients. Overall, evidence of increased comorbidities such as metabolic syndrome, cardiovascular disease, gout, and osteoporosis associated with AS is consistent with the findings of our study. [21] [22] [23] [24] More interestingly, patients with above stated comorbidities appeared to have a higher risk of nephrolithiasis. 25, 26 Although there was a trend of increased female stone disease over the past decades, 27 the male sex is still an independent risk factor of nephrolithiasis. Scales et al. 28 stated that female odds ratio was 0.63 in a 16-year large scale study (n=12,110). While in their review, Seitz and Fajkovic 29 asserted that males tended to have a higher risk of nephrolithiasis than females, with nephrolithiasis male-to-female ratio ranging from 3.1 to 1.2 in the USA and Europe. This finding is consistent with the findings of our study which male predominance in nephrolithiasis was observed in both the AS and non-AS cohorts (male-to-female ratio 2.1 and 2.27, respectively) and this further validated the fact that males with or without AS tend to have a higher risk of nephrolithiasis.
The overall frequency of nephrolithiasis in our cohort study was approximately 4.8%, which was lower than the figures of other previous studies conducted in Taiwan. 30, 31 One possible reason for such a low figure might be the fact that only newly diagnosed cases of nephrolithiasis from 2000 to 2011 were included in our research. Also, since only data of actual visits to medical institutions were evaluated in our research, the prevalence of nephrolithiasis in our study may have been underestimated.
As stated earlier, data used in this populationbased study were collected from the NHIRD. The use of such a database lowered the cost of our research, while at the same time, allowing us to acquire a large sample size over a relatively long time span. In addition, since this study was performed in Taiwan, of which 98% of residents are Han Chinese, the homogeneity of our sample population kept our research free from racial bias.
Despite the significant findings we obtained from our research, there are still some limitations of this study. First, many important information such as diet habits, cigarette or alcohol consumption, body weight, and family history of systemic disease was not disclosed in the NHIRD. Second, the severity and disease duration of AS could not be evaluated simply by using the ICD-9-CM coding. Third, the retrospective data generally has more confounding variables than the prospective clinical trials. Nevertheless, given the high prevalence of stone diseases in Taiwan, we hope our research offers insight into the study of nephrolithiasis in AS subgroup.
In conclusion, to our knowledge, our research is the largest Han Chinese study which assessed the risk of nephrolithiasis among AS patients compared to matched general population based on a nationwide data. Our results showed that patients with AS are more likely to be associated with nephrolithiasis than non-AS patients.
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